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Reciprocal Packaging of the Main
Structural Proteins of Type 1
Fimbriae and Flagella in the Outer
Membrane Vesicles of “Wild Type”
Escherichia coli Strains
Sarah A. Blackburn, Mark Shepherd and Gary K. Robinson*
School of Biosciences, University of Kent, Canterbury, United Kingdom
Fundamental aspects of outer membrane vesicle (OMV) biogenesis and the engineering
of producer strains have been major research foci for many in recent years. The focus
of this study was OMV production in a variety of Escherichia coli strains including wild
type (WT) (K12 and BW25113), mutants (from the Keio collection) and proprietary [BL21
and BL21 (DE3)] strains. The present study investigated the proteome and prospective
mechanism that underpinned the key finding that the dominant protein present in E. coli
K-12 WT OMVs was fimbrial protein monomer (FimA) (a polymerizable protein which is
the key structural monomer from which Type 1 fimbriae are made). However, mutations
in genes involved in fimbriae biosynthesis (1fimA, B, C, and F ) resulted in the packaging
of flagella protein monomer (FliC) (the major structural protein of flagella) into OMVs
instead of FimA. Other mutations (1fimE, G, H, I, and 1lrhA–a transcriptional regulator
of fimbriation and flagella biosynthesis) lead to the packaging of both FimA and Flagellin
into the OMVs. In the majority of instances shown within this research, the production
of OMVs is considered in K-12 WT strains where structural appendages including
fimbriae or flagella are temporally co-expressed throughout the growth curve as shown
previously in the literature. The hypothesis, proposed and supported within the present
paper, is that the vesicular packaging of the major FimA is reciprocally regulated with
the major FliC in E. coli K-12 OMVs but this is abrogated in a range of mutated, non-WT
E. coli strains. We also demonstrate, that a protein of interest (GFP) can be targeted to
OMVs in an E. coli K-12 strain by protein fusion with FimA and that this causes normal
packaging to be disrupted. The findings and underlying implications for host interactions
and use in biotechnology are discussed.
Keywords: Escherichia coli, OMV, FimA, Flagellin, FliC
INTRODUCTION
The role of outer membrane vesicles (OMVs) in a range of bacteria has been the subject of intense
research in recent years since they were first shown in Vibrio cholerae by electron microscopy in
the 1960’s (Chatterjee and Das, 1966; Work et al., 1966). Their diversity and ubiquity have been
shown extensively and the principal foci has been on their pathogenic roles in a range of organisms
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with their proteomes [Myxococcus xanthus (Kahnt et al., 2010);
Pseudomonas aeruginosa (Choi et al., 2011); Campylobacter
jejuni (Jang et al., 2014)] being much more studied than
their lipidomes [Klebsiella pneumoniae (Jasim et al., 2018);
Haemophilus influenzae and Vibrio cholerae (Roier et al., 2016)].
Over this time, the range of cargoes that are carried by OMVs
has grown, encompassing DNA (Deatherage et al., 2009), RNA
(Ghosal et al., 2015), and a wide range of proteins (Horstman and
Kuehn, 2002; Kaparakis-Liaskos and Ferrero, 2015).
Outer membrane vesicle formation has been speculated to play
a variety of roles in intra- and inter- cellular communication as
well as a specific secretion pathway (Guerrero-Mandujano et al.,
2017). Strong bodies of evidence now support the hypothesis that
the loading of OMVs is a regulated mechanism and does not arise
due to random events nor cell death in a vast array of species
(Schwechheimer et al., 2014; Schwechheimer and Kuehn, 2015).
Recently, and especially since the advent of “synthetic biology,”
it has also been recognized that OMVs may be beneficial for the
delivery of cargo and for “synthetic” vaccines and cancer therapy
using Escherichia coli strains (Gujrati et al., 2014; Hedari et al.,
2014). OMVs are non-viable but mimic their producer cells and
possess a range of beneficial features such as multiple epitopes
and adjuvancy (Acevedo et al., 2014; Sanders et al., 2015).
Escherichia coli is the prokaryotic workhorse of microbiology
and industrial biotechnology and has been sequenced and
annotated across a broad range of strains to underpin resources
such as the EcoCyc database1. Some strains of E. coli can
also become pathogenic and cause a range of diseases such as
urinary tract infections, kidney infections, cystitis, cholangitis,
food poisoning, and bacteremia. Treatment for infections caused
by E. coli is also becoming more difficult as they have developed
resistance mechanisms to most first-line antibiotics (Poirel et al.,
2018). Virulence factors of pathogenic E. coli include adhesins,
flagella, fimbriae, and hemolysin. Within this study, OMVs
produced by both E. coli K-12 and B strains are directly
compared. The origin of the E. coli K-12 strain can be traced to
a stool sample in 1922 at Stanford University (Bachmann, 1972).
Although the origins of the E. coli B strain are unclear, it led to
the widely used BL21 strains which are chemically competent and
suitable for transformation (Bachmann, 1972). For the present
study, it is important to note that one of the main differences
between E. coli B strains and K-12 strains is that B strains are
deficient in producing fimbriae and flagella.
While each strain might share some broad characteristics
in genotype and phenotype, the variability in composition and
characteristics in E. coli OMV formation within the literature is
stark [e.g., BL21 (DE3) in Thoma et al. (2018) cf. Nissle 1917
in Hong et al. (2019)]. In many E. coli studies, OMV biogenesis
and yield are studied post-engineering to discover what factors
underpin cargo and composition for use in biotechnology and
do not possess the virulence determinants (e.g., fimbriae and
flagella) that are ubiquitously present in wild type (WT) strains
(Lane et al., 2007; Cooper et al., 2012). We have attempted to
do this herein to discover how OMV formation may be affected
by the host genome and may underpin their use as a chassis for
1https://ecocyc.org/
engineering cells. Importantly, we have considered the formation
and composition of OMVs when structures such as fimbriae
and flagella (important in motility and adhesion/invasion) are
co-expressed in WT and mutant strains.
The present study focused on the effect of modifying the
genome of an E. coli strain in an attempt to create an
engineered OMV producer (i.e., that had capability to allow
protein targeting). During these studies, E. coli K12 clearly
demonstrated protein targeting [of fimbrial protein monomer
(FimA) and/or flagella protein monomer (FliC)] to OMVs in
particular strain backgrounds. Moreover, the mutually exclusive
targeting and packaging of FimA and FliC to OMVs were shown
for the first time and could be rationalized on the basis of
their competing effects in host systems (Cooper et al., 2012).
Using this information, the specificity of this targeting was
investigated using FimA to explore the feasibility of engineering




Escherichia coli strains and sources were as follows:
From the Keio collection (Baba et al., 2006) strain number
indicated in brackets: B Strain (#2507), MG1655 (#6300),
BW2513 (#7636), 1fimA (#11065), 1fimB (#11063), 1fimC
(#11066), 1fimD (#11607), 1fimE (#11064), 1fimZ (#11159),
1fimF (#11067), 1fimG (#11770), 1fimH (#11068), 1fimI
(#11573), 1fliC (#9586), 1lrhA (#11785), fliD (#9587), fliS
(#9588), and flhA (#9554).
From New England BioLabs: BL21 (DE3) (#C25271) and
BL21 (#C2530H).
From Dr. Ian Blomfield, University of Kent: FimB-LacZ
(#BGEC056, El-Labany et al., 2003) and Fimbriae production
locked on strain (#AAEC356, McClain et al., 1993).
From Professor Sander Tans, AMOLF, Netherlands: MG1655
with FimA-GFP (Adiciptaningrum et al., 2009).
Clinical isolates, all obtained from Dr. Mark Shepherd,
University of Kent. Strains 1, 5, and 6 (East Kent Hospitals
University NHS Foundation (#MS207, #MS190, and #MS234
respectively). Strain 2 (#MS10, Totsika et al., 2011), Strain
3 (#MS1, Welch et al., 2002), and Strain 4 (#MS343,
Klemm et al., 2006).
Further descriptions of the strain characteristics can be found
in Supplementary Information 1.
Microbial Cultivation
Media
All media was prepared by addition of components listed to
the desired volume of distilled water which were then sterilized
by autoclaving. The main media used for bacterial growth
was Lysogeny broth (LB) composed of 10 g/L Bacto tryptone,
5 g/L Bacto yeast extract, and 5 g/L sodium chloride. 25 µg/ml
chloramphenicol was added to LB when required for selection.
Agar (Oxoid) was added (20 g/L) to media before autoclaving for
the preparation of agar plates.
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Growth Conditions
Escherichia coli strains were inoculated into LB and incubated
at 37◦C, shaking at 180 RPM for 18 h unless otherwise stated.
A Shimadzu UV-1800 spectrophotometer was used to measure
the optical density of cultures (at 600 nm).
Cell Fractionation and OMV Purification
Standard Protocol for Purifying OMVs From
Gram-Negative Bacteria
The OMV purification protocol was adapted from Nieves et al.
(2010). The strain of interest was inoculated into 500 ml–1 L LB
media and incubated at 37◦C, 180 RPM for 18 h. The bacterial
culture was pelleted by centrifugation at 12,000 RPM (14,515× g)
for 10 min at 4◦C. The supernatant (containing OMVs) was
extracted and filtered through a 0.45 µm polyethersulfone (PES)
membrane filter (Nalgene Rapid-Flow) to remove any whole
bacterial cells or large bacterial fragments. To ensure that all
live bacterial cells had been removed, 500 µL–1 mL of filtered
supernatant was spread onto LB agar plates and incubated for
24–48 h at 37◦C to check for growth. OMVs were precipitated
out of solution by slowly adding 1.5 M ammonium sulfate then
incubated overnight at 4◦C with gentle stirring. The OMVs
were pelleted by centrifugation at 16,000 RPM (25,805 × g) for
30 min at 4◦C. The resulting OMV pellets were resuspended
in 10 mM N-2-hydroxyethylpiperazine-N-ethanesulfonic acid
(HEPES)/0.85% NaCl, pH 7.4 for further analysis.
Standard Protocol for Purifying OMVs From
Competent Cells Containing Desired Plasmid
One colony from a successful transformation was inoculated into
50 ml LB containing 25 µg/ml chloramphenicol and incubated
at 37◦C, 180 RPM overnight to generate a starter culture. The
culture was diluted one in 100 in fresh LB with 25 µg/ml
chloramphenicol (500 ml total volume). Cells were induced to
express the desired plasmid by addition of 0.5 mM isopropyl
β-d-1-thiogalactopyranoside (IPTG) at an OD600 of 0.25–0.3
(early stationary phase). When the induced cells had reached an
OD600 of 1.0, OMVs were purified using the standard protocol
for Gram-negative bacteria outlined above.
Outer Membrane and Periplasmic Protein Extractions
Outer membrane (OM) proteins and periplasmic proteins were
isolated using Tris/sucrose/EDTA (TSE) buffer extraction (Quan
et al., 2013). Isolation of periplasmic proteins, OM proteins and
OMVs were performed on the same E. coli culture concurrently
for direct comparison. In each case, the colony of interest was
inoculated into 750 ml LB and grown overnight. 500 ml of this
culture was used to purify OMVs and 100 ml was used for the
periplasmic and OM extraction.
OMV Characterization
Microscopy
Standard transmission electron microscopy protocol to
visualize OMVs
Outer membrane vesicles resuspended in HEPES buffer were
concentrated for electron microscopy (EM) by centrifugation
at 13,200 RPM (14,220 × g) for 30 min at 4◦C. The OMV
pellets were resuspended in 10 µl HEPES buffer and added to
a formvar/carbon-coated copper EM grid (mesh size 400) and
left to settle for 10 min. OMVs were then fixed by adding 10 µl
of 4% formaldehyde in PBS for 10 min. The grids were subject
to 4 × 1 min water washes then negatively stained using 2%
uranyl acetate in water. Grids were air dried and loaded on to the
Jeol transmission electron microscope (model JEM 1230). Photos
taken using a Gatan multiscan digital camera and operated at an
accelerating voltage of 80 kV.
Embedding bacterial cells and omvs in resin for immunogold
labeling and TEM analysis
Methods used for embedding bacterial cells and OMVs in
resin for immunogold labeling were developed based on a
protocol in the literature (Lee et al., 2016). See Supplementary
Information 2 for details on embedding, sectioning,
immunogold labeling and visualization of embedded samples.
Protein Manipulation Techniques
Bradford assay
The concentration of protein in cells, outer membrane fractions,
periplasmic fractions and OMV samples were determined
using a Bradford assay. Bradford reagent (Bio-Rad catalog #
5000006) was used and the assay was performed as per the
manufacturer’s instructions.
TCA precipitation of OMVs
Purified OMVs [resuspended in HEPES (HEPES is
10 mM + 0.85% NaCl adjusted to pH7.4 and filter sterilized)]
were thoroughly mixed with cold 100% trichloroacetic acid
(TCA) stock solution (Sigma-Aldrich catalog #T4885) to make
a final concentration of 20% TCA. Samples were incubated on
ice for 30 min then centrifuged at 13,200 RPM (14,220 × g)
for 30 min at 4◦C. The supernatant was removed and the pellet
was resuspended in 0.5 ml ice-cold acetone. The samples were
centrifuged at 13,200 RPM (14,220 × g) for 15 min at 4◦C. The
supernatant was removed and each pellet was resuspended in
HEPES and 4x RSB (Reducing Sample Buffer, Invitrogen catalog
#NP0008) in a 3:1 ratio.
SDS-PAGE
Samples were standardized to the same protein concentration
then subject to TCA precipitation to concentrate. Each sample
was then mixed with the appropriate volume of 4x RSB and
heated to 95◦C for 5 min. SDS-PAGE (sodium dodecyl sulfate–
polyacrylamide gel electrophoresis) gels were run using the
Invitrogen Novex Xcell II Mini-Cell system for Electrophoresis
with NuPAGE pre-cast 10 well 4–12% Bis-Tris gels. 20 µl of
each sample was loaded into each well. 0.2 µl markers (Bio-
Rad, catalog #1610374) were used each time to estimate protein
size when visualized using silver staining and 5 µl for Western
blotting. Gels were run at 165 V for 48 min in MES [2-(N-
morpholino) ethanesulfonic acid] running buffer or 55 min in
MOPS [3-(N-morpholino) propanesulfonic acid] running buffer.
Detection of proteins via silver staining
SDS-PAGE gels were developed using the Pierce Silver Stain
kit (Thermo-Fisher catalog #24612) as described in the
manufacturer’s protocol.
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Western blot protocol
Transfer of proteins from an SDS-PAGE gel to a PVDF
membrane was performed using the Bio-Rad electro transfer
cell equipment (catalog #1703930) following the manufacturer’s
instructions. All steps below were carried out on an orbital shaker
(Stuart Scientific). After transfer, the membrane was blocked in
5% (w/v) milk powder in 10 mM Tris, 137 mM NaCl, 0.1%
Tween 20 at pH 7.4 (TBST) for 30 min then incubated overnight
at 4◦C with primary antibody diluted in 5% milk in TBST (see
Supplementary Information 3 for details of dilutions for each
primary antibody). Membranes were then subject to 4 × 5 min
washes in 1X TBST then incubated for 1 h with secondary
antibody (diluted 1:5,000 in 5% milk in TBST). Membranes
were then subject to 4 × 5 min washes in 1X TBST. Bands
were developed in the dark using BCIP/NBT substrate (Sigma-
Aldrich) for 1–10 min.
Imaging of SDS-PAGE gels and western blots
Gels and blots were imaged using Syngene G:BOX and associated
software.
Mass spectrometry (matrix-assisted laser
desorption/ionization, MALDI).
SDS-PAGE gels containing the bands of interest were subject to
2 × 10 min washes with ultrapure water. Bands of interest were
then carefully excised from the SDS-PAGE with a clean washed
scalpel and cut further into 1 mm × 1 mm squares. A protocol
for in-gel digestion was carried out as described in Shevchenko
et al. (1996). Proteins were identified using Bruker ultrafleXtreme
MALDI-TOF/TOF mass spectrometer and associated software.
See Supplementary Information 4 for further information.
Proteinase K test
The protocol for the Proteinase K test was adapted from McCaig
et al. (2013). Purified OMV samples were treated with a working
concentration of 10 µg/ml Proteinase K (resuspended in 10 mM
HEPES/0.85% NaCl/20 mM CaCl2 buffer, pH 7.4) and/or varying
concentrations of SDS (in sterile ultrapure water). The OMVs
(resuspended in HEPES buffer) were incubated in the presence
and absence of Proteinase K and SDS for 30 min at 37◦C.
Phenylmethylsulfonyl fluoride (Sigma-Aldrich) was added to
every sample (at a working concentration of 0.5 mM) to inhibit
Proteinase K and incubated for 30 min at 37◦C. Samples were




A plasmid (pSB001) was constructed to produce a FimA-
mNeon Green protein fusion with a N-terminal hexa-histidine
tag. Primers used were from Integrated DNA Technologies
(IDT). Further plasmid and primer information can be found in
Supplementary Information 5.
Preparation of Competent Cells
Escherichia coli parental BW25113 (CGSC #7636) and E. coli
1fimA (CGSC #11065) were made chemically competent using
standard protocols (Ausubel et al., 1994).
DNA Manipulation
The cloning techniques used in this study were carried out using
standard protocols (Ausubel et al., 1994). Plasmid DNA was
isolated using the Plasmid Miniprep kit (Qiagen) and AscI and
NdeI restriction enzymes were purchased from New England
BioLabs. PCR reactions were performed in Veriti 96 Well
Thermocycler (Applied Biosystems). Agarose gels were prepared
using the multiSUB Midi electrophoresis unit, 10 cm × 10 cm
UV Tray, 2 × 16 sample combs, loading guides, and dams.
1 or 2% agarose gels were run at 150 V for 25 min on the
Fisherbrand multiSUB Midi Horizontal Gel System then stained
for 30 min in 0.5 µg/ml ethidium bromide in ultrapure water.
Bands were visualized using G:Box machine by SynGene and
associated software. Lastly, samples were sent to Genewiz for
Sanger Sequencing2.
RESULTS
Characterizing the Proteome of
Escherichia coli K12 and Escherichia coli
B Strains
There have been many studies of OMV formation in a range of
bacterial species and strains. Herein we investigated how different
E. coli strains, the major chassis for many biotechnological
processes, vary in OMV yield and composition. All E. coli
strains were grown at 37◦C, 180 RPM for 18 h to reach
late stationary phase. OMVs were purified concurrently from
two recombinant E. coli B strains: BL21 and BL21 (DE3)
and two E. coli K-12 strains: E. coli WT MG1655 and
E. coli FimB-LacZ fusion strain (where fimbriae production
is locked off). As outlined in the Introduction, these strains
differ in their production of fimbriae and flagella and the
methods used to distinguish between the two are outlined
in Supplementary Information 6. They are absent in BL21
strains but present in the K12 strain MG1655 (which expresses
Type 1 fimbriae) and the FimB-LacZ protein fusion strain
which possesses flagella (as fimbriae production is locked off)
(Figure 1A).
At present, the variability in the proteins associated with E. coli
OMVs is not well documented, especially when comparing WT
strains with proprietary strains. As shown in Figure 1, there
is a significant difference in both the OMV yield (Figure 1A)
and the OMV protein profile (Figure 1B) of the WT K12
strains when compared with the E. coli B strains [BL21 and
BL21 (DE3)]. Both E. coli BL21 and BL21 (DE3) have a
diverse array of proteins when compared with K12 strains
that have clearly demonstrable enrichment of very few proteins
(Figure 1B). These proteins were analyzed by mass spectrometry
and the results are shown in Supplementary Information 7 and
Figure 1. As highlighted, it is shown that the dominant and
identifiable proteins were monomeric FimA (the main structural
protein of Type 1 fimbriae) in E. coli MG1655 OMVs and
Flagellin/FliC (main structural protein of flagella) in E. coli
2https://www.genewiz.com/en-GB/
Frontiers in Microbiology | www.frontiersin.org 4 February 2021 | Volume 12 | Article 557455
fmicb-12-557455 February 8, 2021 Time: 18:12 # 5
Blackburn et al. Regulated Reciprocal Packaging in Escherichia coli
FIGURE 1 | Comparison of the OMV yield (A) and proteome (B) from E. coli K-12 wild type MG1655 strain, FimB-LacZ fusion strain (where fimbriae production is
locked off) vs. B [BL21 and BL21 (DE3)] strains. OMVs were purified concurrently for a direct comparison. Samples were from the same harvest points and with
equivalent gel loading concentrations. It is noted that OMVs from E. coli K-12 strains were co-purified with either flagella (1) or fimbriae ().
FimB-LacZ fusion protein OMVs. Interestingly, the packaging
of FimA and FliC within E. coli K-12 OMVs appeared to be
mutually exclusive.
FimA (Type 1 Fimbriae Major Subunit)
and FliC (Major Flagella Filament
Structural Protein) Are Reciprocally
Packaged Into Wild Type Escherichia coli
OMVs
Using different strains, we investigated further whether FimA or
FliC is present in E. coli K-12 whole cells, periplasmic fractions
and OMVs. When comparing a K-12 WT strain (BW25133) with
a fimA or fliC mutant, it can be seen that either FimA or FliC is
enriched in the OMV samples (Figures 2A,B). Additionally, if the
abundance of each of the monomers (FimA or FliC) is compared
with whole cells and periplasmic fractions, it is evident that FimA
(in BW25113 and 1fliC) and FliC (in 1fimA) are enriched in the
OMV samples (Figures 2B,C).
It can also be concluded from these results that FimA is the
key protein in the E. coli K-12 (BW25113) OMV proteome.
However, the main cargo found in the OMV switches from
FimA to FliC when there is a single gene deletion (1fimA)
or the regulation of Type 1 fimbriae is disrupted (FimB-LacZ
strain) i.e., there is a switch from the most abundant structural
protein in fimbriae (FimA) to the most abundant structural
component of flagella (FliC). See Supplementary Information 7
for mass spectrometry details. A Proteinase K test was also
performed to distinguish which proteins are outside the OMVs
and which are protected within the lumen. These experiments
clearly showed that flagellin (FliC), but not FimA, was accessible
and hydrolyzed by Proteinase K only when SDS was present
to disrupt the integrity of the OMVs (see Supplementary
Information 8).
Abrogation of Fimbrial Assembly Alters
OMV Cargo
The biosynthesis of fimbriae in E. coli is controlled by the fim
operon which co-ordinately regulates 8 genes (fimA-H) via the
invertible 314 bp fim switch comprising the recombinases FimB
and FimE (Gally et al., 1994). Using the Keio collection (Baba
et al., 2006), we investigated how different deletion mutants
would alter both the formation of the OMVs and the proteomes
therein. While it may have been expected that the biosynthesis
of fimbriae and the loading of “monomeric” FimA into OMVs
is linked, it is not a clear-cut story. Using the bank of Keio
mutants in conjunction with the WT strain (BW25113), it can
be seen that all form OMVs but the presence or absence of either
fimbriae or flagella varied (Figure 3A). It may have been expected
that any mutant that affects the formation of flagella (such as
1fliC) leads to fimbriae formation and any mutant that effects
fimbriae formation (1fimA, B, C, D, E, F, G, H, I, and Z) leads
to flagella formation but this was not shown with 1fimE and
1fimZ producing fimbriae and 1fimI appearing to produce both
fimbriae and flagella.
The proteomes of the OMVs from each mutant strain were
examined and this is shown in Figures 3B,C, Supplementary
Information 7, and Figure 3. Two antibodies were used to
distinguish between monomeric FimA (which has the potential
to be OMV-associated) and polymerized FimA (which forms
the main structure of Type 1 fimbriae). Monomeric FimA was
detected at 18 kDa while remaining undenatured polymeric
FimA was detected in the wells of the SDS-PAGE gel. This is
because the structure of type 1/polymerized FimA fimbriae is too
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FIGURE 2 | Enrichment and location of preferentially packaged proteins in the OMVs of E. coli. The co-purification of either fimbriae () or flagella (1) but not both is
highlighted next to TEM images of OMV preparations derived from K12 strains (A). FimA and Flagellin are enriched in E. coli K-12 OMVs compared to levels in the
periplasm and whole cell (B,C).
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FIGURE 3 | The effect of mutations in various genes of the fim operon using WT (E. coli BW25113) and mutants from the Keio collection. (A) OMV co-purification
with either fimbriae () or flagella (1); (B) Proteome of the OMVs labeled with proteins identified by mass spectrometry (C) Western blot using anti-FimA (monomer
and polymerized) and anti-Flagellin antibodies.
large to migrate through the gel and therefore this is the area
examined after Western blotting (Figure 3C). In the WT strains,
the arising OMVs contained monomeric FimA as the dominant
protein (and no FliC present). Mutants in fimA, fimB, fimC
(periplasmic chaperone for fimbrial proteins) and fimF (fimbrial
tip protein) altered the OMV proteome which was shown to
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contain FliC as the major protein (with no FimA present).
Interestingly, mutations in fimE (fimbrial production locked
off switch), fimG (fimbrial minor subunit), fimH (adhesin on
fimbrial tip), and fimI (fimA homolog with unknown function)
disrupted the exclusivity leading to both FimA and FliC being
packaged into the OMVs.
Polymerized FimA (within Type 1 fimbriae) was
detected in the following samples: WT (BW25113),
1fliC,1fimE,1fimI,1fimZ [activator of the promoter to
express the fim structural genes in Salmonella (Saini et al.,
2009)], MG1655, and fimbriae locked on strains. Interestingly,
Figure 3C indicated that 1fimG and 1fimH OMV samples
contained no polymeric FimA but did contain FimA monomer.
These results suggested that the FimA monomers are packaged
independently of fimbrial formation and/or packaging of OMVs
is coordinately regulated and abrogation of that control leads to
mispackaging. 1fimE and 1fimI are key to this demonstrating
that altered regulation leads to both FimA (monomers) and
Flagellin (monomers) being packaged in the OMVs. See
Supplementary Informations 9, 10 for summary tables of
these findings and Supplementary Information 11 for further
discussion of each finding.
The Effect of Regulatory Mutants on the
Composition of OMVs and Co-purified
Appendages in Escherichia coli WT (BW
25113)
It might be expected that other control systems, known to
regulate the synthesis of either fimbriae or flagella, also modulate
the packaging of cargo into OMVs. If disrupted, this may cause
the dysregulation of the packaging of FimA and FliC into OMVs.
As can be seen in Figures 4B,C, only 1lrhA (a deletion in a key
transcriptional regulator of fimbriation and flagella biosynthesis
via the master regulator FlhDC, Lehnen et al., 2002; Blumer
et al., 2005) caused dysregulation where both FimA and FliC were
packaged into OMVs (see Supplementary Information 7 and
Figure 4 for MS identification). It can also be seen that 1lrhA
caused production of both fimbriae and flagella on the OMV-
producing cell. Lastly, OMVs were also purified from E. coli
strains containing knockouts of various proteins associated with
flagella biosynthesis: 1fliD,1fliS, and 1flhA. Absence of these
genes had no effect on the packaging of FimA in the OMVs
produced (Figures 4B,C).
Investigating Mutual Exclusion in
Escherichia coli Clinical Isolates
Having demonstrated that FimA and FliC appear to be packaged
in a mutually exclusive way, it was interesting to speculate
whether this was also true of clinical isolates. In a small
study, six clinical isolates were examined using EM, SDS-
PAGE, Western blotting and mass spectrometry to ascertain
whether FimA and/or FliC monomers were packaged in OMVs
(Figures 5A–C and see Supplementary Information 7; Figure 5
for MS identifications). Clinical isolate 5 OMVs contained FimA
monomer and no FliC and Clinical isolate 6 OMVs contained
FliC but no FimA monomer, which fits the mutual exclusivity
hypothesis. However, Clinical isolate 3 contained both FimA and
FliC, which means that the mutual exclusivity theory is not a
clear picture. Further discussion on these findings can be found
in Supplementary Information 11. Lastly, all isolates appeared
to contain OmpA within their OMVs which is a multifunctional
membrane protein and known modulator of infection and
virulence determinants (Wang, 2002; Ortiz-Suarez et al., 2016).
Use of FimA as a Potential Delivery Tag
in Escherichia coli OMVs
A major motivation for understanding OMV synthesis in
bacterial strains is to manipulate the cargo to enrich the OMVs
for chosen proteins and other small molecules. Herein, we have
shown that FimA and FliC appear to be selectively enriched in
the OMVs depending on the prevailing regulatory conditions.
We speculated that it should be possible to selectively target
proteins to the OMVs using FimA although we were not clear
whether FimA alone was sufficient or what part of the protein
was necessary to facilitate correct targeting. We obtained and
created two proteins that were differentially tagged with either
GFP (chromosomal FimA + GFP) or Neon Green (exogenously
expressed FimA + Neon Green as outlined in section “Materials
and Methods”). We found that use of the two constructs gave two
contrasting results.
Firstly, Figure 6A indicates that fimbriae production in the
E. coli MG1655 FimA-GFP (Adiciptaningrum et al., 2009) was
disrupted and this led to the production of flagella, which was
found co-purified with the OMVs. This was in contrast to the WT
MG1655 strain which produced fimbriae only. When the purified
OMVs were further analyzed (Figures 6B,C), it appeared that
OMVs from the FimA-GFP fusion strain successfully contained
the FimA-GFP fusion protein at 50 kDa. Interestingly, the OMVs
also contained monomeric flagellin at 51 kDa and this appeared
to be present at a higher concentration than the FimA-GFP fusion
protein (Figures 6B,C and see Supplementary Information 5,
Figure 6 for MS identification).
Using antibodies to both GFP and FimA, the FimA-GFP
fusion protein was detected at approximately 50 kDa within
the isolated OMV sample (Figure 6C) and at lower levels
in the periplasm and OM. Therefore, the fusion of GFP to
FimA chromosomally appeared to be sufficient for trafficking
the FimA-GFP protein to the OMVs. Lastly, a transmission
electron microscopy (TEM) analysis of thin-sectioned OMVs
and cells embedded in resin was performed. The sections were
immunogold labeled and probed with the following antibodies:
(i) anti-GFP antibody, (ii) anti-FimA monomer antibody, (iii)
both anti-FimA monomer and anti-GFP antibodies, and (iv)
anti-Flagellin antibody (Figures 6D,E). These images support
the conclusion that the FimA-GFP fusion protein and the
Flagellin monomer protein were present within the OMVs from
this strain.
A plasmid containing a FimA-mNeon green fusion protein
(pSB001) was made and expressed in the E. coli (BW25133) and
1fimA strain. When induced with IPTG, the cells of both strains
appeared to hypervesiculate, giving rise to an increased yield of
OMVs (Figure 7A). The proteome of the producer strains and
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FIGURE 4 | The effect of regulatory mutants on the composition and co-purified appendages in E. coli WT (BW25113). (A) OMV co- purification with either fimbriae
() or flagella (1). (B) Proteome of the OMVs and proteins identified by mass spectrometry (C) Western blot using anti-FimA (monomer and polymerized) and
anti-Flagellin antibodies.
the OMVs were analyzed by Western blotting. It was shown that
the cells produced a FimA-Neon Green protein (when examined
using an anti-Neon Green antibody) but they did not reach the
OMVs (Figure 7B). This finding suggested that the Neon-Green-
FimA construct was either incorrectly processed/targeted which
was further supported by the absence of the construct in either
the periplasm or the OM (Figures 7C,D).
Overall, the results using both the FimA-GFP and the
FimA-NeonGreen constructs show that the disruption of the
endogenous control circuits/regulation in some strains cause
hypervesiculation and dysregulation in the processing and
packaging of OMVs.
DISCUSSION
Unlike all previous studies into OMVs, we have focused the
studies presented on the production of OMVs in E. coli WT
strains that ordinarily produce either flagella (for motility) or
fimbriae (for adherence and invasion) to give us an insight into
the concurrent expression of OMVs and these important co-
occurring cellular features. Previous studies have demonstrated
that the production and regulation of these appendages are
under complex control with flagella synthesis being dependent
on a multitude of factors such as growth rate (Sim et al., 2017)
and complex pulsatile regulatory networks that produce rich
temporal dynamics and phenotypic heterogeneities (Kim et al.,
2020). Similarly, it is recognized that Type 1 fimbrial production
is a phase variable system that is produced uniformly throughout
the growth curve but subject to regulatory controls such as
CRP-cAMP (Müller et al., 2009). Taken as a whole, while
flhDC and lrhA are recognized as central players in integrated
transcriptional co-regulation of fimbriae and flagella (Lane et al.,
2007), many complex regulatory circuits exist at both the cell and
population level.
The assemblage of these extracellular structures (fimbriae and
flagella) has been extensively reviewed elsewhere (Auvray et al.,
2001; Nishiyama et al., 2005). The main structural subunits of
these structures are formed by polymerization of monomers
(FimA/FliC) that are delivered to the base of a growing filament
in either the periplasm (fimbriae) or the cytoplasm (flagella).
In this way, they are spatially separated and delivered via
different mechanisms. Moreover, the function of fimbriae and
flagella (principally invasion and motility) are mutually exclusive
although there are suggestions that both are involved in adhesion
and virulence events (Haiko and Westerlund-Wikström, 2013).
Despite their ubiquity and co-occurrence in E. coli WT strains, it
is noted that very few OMV studies acknowledge this and suggest
that the purification of the OMVs by ultracentrifugation allows
clean separation of the fimbriae or flagella.
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FIGURE 5 | The ubiquity of mutual exclusivity using E. coli WT, deletion mutants (1fimA and 1fliC) and a range of E. coli clinical isolates (described in section
“Materials and Methods”). (A) OMV co-purification with either fimbriae () or flagella (1). (B) Proteome of the OMVs and (C) Western blot using anti FimA (monomer
and polymerized) and anti-Flagellin antibodies. Proteins identified in panel (B): 1, Flagellin; 2, FimA; 3, Antigen 43α chain; 4, OmpA; 5, FimH; 6, KS71A fimbrillin; 7,
F7-2 fimbrial protein precursor.
A key finding in the present work was the clear demonstration
of the presence of the major structural monomers [either FimA
(from fimbriae) or FliC (from flagella)] in OMVs arising from
E. coli K-12 strains. This is in contrast to E. coli strains that
are stressed or engineered e.g., BL21 strains which are shown to
hypervesiculate and appear to contain non-specific protein cargo
(Figure 1). FimA and Flagellin are rarely found as monomers i.e.,
not in the polymerized form. FimA is the major structural protein
in fimbriae and the monomers are synthesized and delivered to
the bottom of the growing fimbriae by crossing the periplasm
in a highly regulated chaperone/usher pathway in a wide variety
of bacterial phyla (Liu and Ochman, 2007). FliC is the major
filamentous protein in the flagella and is delivered to the growing
filament within the MS ring/basal body present in the cytoplasmic
membrane. Therefore, it was interesting to find monomeric FimA
and Flagellin (that are formed in different regions of the cell)
present in OMVs purified from WT strains.
It was also shown that the mutual exclusivity of the
FimA (fimbrial monomer) and FliC (flagella monomer) is
abrogated if some components of the regulation and assembly
pathway were mutated/attenuated. As shown in Figures 2–5, the
absence of components essential for the correct regulation and
polymerization of FimA into fimbrial appendages (1fim B, C, D
and F) predominantly prevented FimA packaging into OMVs.
Additionally, if the “correct” WT packaging of FimA did not
occur, then it was shown that FliC was packaged instead (1fim A,
B, C, and F). When OMVs were analyzed from six clinical isolates,
clinical isolate 5 OMVs contained FimA (but no Flagellin), and
clinical isolate 6 contained Flagellin (but no FimA) which fits
the mutual exclusivity hypothesis (Figure 5). However, OMVs
from clinical isolate 3, 1fimE, G, H, and I contained both FimA
and FliC packaged within the OMVs so this is not a clear-cut
story. See Supplementary Information 11 for further hypotheses
on these findings.
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FIGURE 6 | The transport and packaging of a GFP-FimA fusion protein in E. coli MG1655. (A) OMV co-purification with either fimbriae or flagella; (B) Proteome of
the OMVs and (C) Western blot using anti FimA (monomer and polymerized) and anti-Flagellin antibodies. (D,E) TEM analysis of thin-sectioned OMVs (D) and E. coli
FimA-GFP strain cells (E) embedded in resin. The sections were immunogold labeled and probed with: anti-GFP antibody, anti-FimA monomer antibody, anti-FimA
monomer/anti-GFP antibodies mixed and anti-Flagellin antibody. As a negative control, the embedded OMVs were incubated in TBST only (no primary antibody).
The samples were then incubated with the following secondary antibodies: 15 nm gold label or 10 nm gold label.
Our findings led us to speculate on the possible advantages of
the reciprocal regulation of fimbrial (FimA) and flagellar (FliC)
monomers within E. coli OMVs. For example, it is likely to
mirror the reciprocal regulation of adherence (by production of
Type 1 fimbriae) and motility (by production of flagella) shown
previously in UPEC E. coli (Cooper et al., 2012). In addition
to this, it might further be reasoned on the basis of competing
immunomodulation and immunevasion phenotypes for each of
the two proteins in various hosts and niches:
FimA monomer – Immunoevasion/immunomodulation – as
planktonic or adhering cells, it makes sense that an abundant
protein (FimA) possesses gain of function to suppress host via
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FIGURE 7 | The transport and packaging of a mNeonGreen-FimA fusion protein in E. coli BW25113 and a 1fimA mutant. (A) TEM images show purified OMVs from
the E. coli BW25113 and 1fimA mutant strains containing the pSB001 plasmid (encoding the mNeonGreen-FimA fusion protein) in presence or absence of IPTG.
(B) Presence of mNeon green in either the cells or OMVs of the WT and 1fimA mutant both in the presence or absence of IPTG induction. (C) Western blot using
anti-Neon green on whole cells and subcellular [periplasm, outer membrane (OM) and OMV] fractions in the presence and absence of IPTG induction. (D) As C using
anti-FimA monomer and anti-Flagellin antibodies.
OMV packaging. Its role has previously been demonstrated
by Sukumaran et al. (2010) who suggested a FimA homolog
could suppress host cell apoptosis by targeting a mitochondrial
complex, the Bax-mediated release of cytochrome C. FimA has
also been found in OMVs from other bacterial strains including
Porphyromonas gingivalis (Mantri et al., 2015).
Flagellin monomer – Immunostimulation – Flagellin
enrichment in OMVs has previously been shown in E. coli
K12 (W3110) (Manabe et al., 2013), Enterotoxigenic E. coli
(ETEC), and Pseudomonas aeruginosa PA01 and S470, a
clinically relevant strain originating from a cystic fibrosis patient
(Bauman and Kuehn, 2006). Flagellin is a virulence factor that
is recognized by the innate immune system and known to
induce a pro-inflammatory immune response in mice (Zgair,
2012), recognition by the NAIP5/NLRC4 inflammasome (Hajam
et al., 2017) and known to bind both TLR-5, activating NF–κB
signaling (Yoon et al., 2012) and TLR-11 (Hatai et al., 2016).
Counter to this, there is clear evidence that, in Salmonella,
while flagella interacts with TLR5, monomeric flagellin does not
(Hayashi et al., 2001).
Finally, the present work sought to use the knowledge
gained in this study to engineer a strain capable of
selectively transporting a cargo protein to the OMV. Two
approaches were used in the study, a chromosomally modified
FimA-GFP obtained from AMOLF in the Netherlands
(Adiciptaningrum et al., 2009) and a construct of pSB001
FimA-mNeon Green (entire). Using the chromosomally
modified FimA-GFP in E. coli MG1655, it was shown that the
FimA-GFP construct (50 kDa) was packaged into the OMVs but
at low concentration, with flagellin being the major protein in
this engineered system (Figures 6B,C). Using the FimA-mNeon
Green constructs (expressed using a plasmid) it was shown
that the fusion proteins did not traffic as expected and were
not packaged into OMVs. It may therefore be concluded that it
may be possible to use FimA to target cargo to OMVs but only
when correctly or endogenously regulating and expressing the
protein. This is simply because OMV targeting and increased
yield, the major criteria for biotechnological production and
downstream harvest and utility, would be better achieved by
use of hypervesiculating strains (e.g., BL21 and derivatives)
with appropriate OMV targeting proteins such as BL21 (DE3)
1ompA (Fantappié et al., 2014). If exceptionally there was a
desire to use a whole-cell OMV producing system capable of
co-producing flagella or fimbriae it would be beneficial to both
induce and overexpress the target and cargo to maximize the
yield of downstream OMVs. Such a design brief was shown not
to be possible using the FimA protein fusions (Figures 6, 7) and
it is concluded that if the endogenous regulation is circumvented
the correct trafficking and packaging of OMVs breaks down
limiting its potential utility.
Frontiers in Microbiology | www.frontiersin.org 12 February 2021 | Volume 12 | Article 557455
fmicb-12-557455 February 8, 2021 Time: 18:12 # 13
Blackburn et al. Regulated Reciprocal Packaging in Escherichia coli
Overall, the work presented in the present paper shows that:
(i) Outer membrane vesicle yield and proteome is tightly
regulated in K-12 WT E. coli strains. While it may
be possible to simply engineer hypervesiculation, this is
shown to be at the cost of selectivity of packaging.
(ii) Monomeric FimA is consistently and selectively enriched
and packaged in the E. coli WT strains including
MG1655 and BW25113.
(iii) FimA and FliC appear to be reciprocally regulated
and generally mirror the regulation of adherence (by
expression of Type 1 fimbriae) and motility (by expressing
flagella) in cells.
(iv) FimA packaging into OMVs is dependent upon other
components of the fim operon. Mutation of genes fimA, B,
C, E, F, G, H, I caused the packaging of FliC into OMVs,
either exclusively or in combination with FimA.
(v) In a study of six E. coli K-12 clinical isolates, two
isolate OMVs contained monomeric FimA and two isolates
contained Flagellin. Two of these isolates contained either
FimA or Flagellin packaged in a mutually exclusive way.
(vi) Using a chromosomally modified FimA-GFP in E. coli
MG1655, it was shown that the FimA-GFP construct
(50 kDa) was successfully targeted to the OMVs.
(vii) Using the FimA-mNeon Green constructs (expressed using
a plasmid) it was shown that the fusion proteins did not
traffic as expected and were not packaged into OMVs.
In summary, the present work shows that two of the major
externally transported and polymerizable proteins in E. coli,
FimA (the major protein in Type 1 fimbriae), and FliC/Flagellin
(the major structural protein in flagella), are reciprocally
regulated and can switch the dominant protein packaged in the
OMVs when normal regulatory circuits are abrogated. The exact
mechanism and reasons for the packaging of such proteins have
been speculated upon herein but are likely to be strain and host
dependent and will require further study.
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